Hilltop National Bank’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$129K Buy
569
+127
+29% +$22.6K 0.03% 334
2026
Q1
$76.2K Hold
442
0.02% 401
2025
Q4
$88.2K Sell
442
-67
-13% -$12.2K 0.02% 361
2025
Q3
$79.6K Hold
509
0.02% 389
2025
Q2
$77.2K Buy
+509
New +$67.9K 0.02% 384
2024
Q4
$69.2K Sell
375
-29
-7% -$5.59K 0.02% 385
2024
Q3
$79.6K Hold
404
0.02% 375
2024
Q2
$83.5K Buy
404
+34
+9% +$7.7K 0.03% 340
2024
Q1
$100K Buy
+370
New +$88.4K 0.03% 304

Other funds holding CRL

Hilltop National Bank's CRL Position: Q2 2026 in Review

Hilltop National Bank increased its Charles River Laboratories (CRL) stake by 29% in Q2 2026, buying an estimated $22.6K and bringing the position to 569 shares worth $129K. The position accounts for 0.03% of the portfolio, ranked #334.

Hilltop National Bank first reported a position in CRL in Q1 2024 and has held it in 9 quarters since. 93 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Hilltop National Bank held 569 shares of Charles River Laboratories worth $129K as of Q2 2026.
  • Hilltop National Bank bought 127 Charles River Laboratories shares in Q2 2026, an estimated $22.6K.
  • Charles River Laboratories made up 0.03% of Hilltop National Bank's portfolio in Q2 2026, its #334 holding.
  • Hilltop National Bank first reported a position in Charles River Laboratories in Q1 2024 and has held it in 9 quarters since.
  • 93 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Hilltop National Bank's 13F filing for Q2 2026, filed 2 Jul 2026.